Emerald Health Therapeutics has signed an agreement with Skye Bioscience.
Lucid Green has announced three new partnerships to support the digitisation of certificates of analysis (COA).
Curaleaf's current CEO Joe Bayern will launch and run a new division of Curaleaf.
Greg Fleury has joined the CBD company.
A new study has concluded that the State’s cannabis tax must be eliminated to move consumers away from illicit products.
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and...
HempStreet and MGC Pharmaceuticals have teamed up to increase access to phytopharmaceutical medicines for patients.
Despite complying with the Farm Bill, a new study has shown that many US THC products are too strong to legally sell in a cannabis dispensary.
With the rise in popularity of cannabis edibles, the problem with “copycat” products that look like popular snacks should be a major concern for the industry.
The platform aims to provide information sharing, reduce costs, and increase transparency and trust.
